Sars-cov-2 vaccines
US-2024408193-A1 · Dec 12, 2024 · US
Medicaments and methods for treating mesothelioma
US9023643B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9023643-B2 |
| Application number | US-68245708-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 10, 2008 |
| Priority date | Oct 10, 2007 |
| Publication date | May 5, 2015 |
| Grant date | May 5, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for preparing spontaneously mature cancer vaccinal dendritic cells in an individual, comprising the following steps: in vitro infection of cancer cells taken from the individual by an attenuated measles strain to yield a cell lysate; and contacting dendritic cells with the cell lysate to yield vaccinal dendritic cells which are spontaneously mature, wherein said method comprises no step of maturation of said dendritic cells consisting of c…
Assignees
Inventors
Classifications
- A61K39/12Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9023643B2 cover?
- The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.
- Who is the assignee on this patent?
- Gauvrit Anne, Tangy Frédéric, Gregoire Marc, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K39/12. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).